Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hypersensitivity Reaction

Free Subscription Articles published in Acta Derm Venereol Retrieve available abstracts of 127 articles: HTML format

Single Articles

August 2026
1. KIND B, Pham C, Heinrich L, Honstein T, et al
   Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.
   Acta Derm Venereol. 2026;106:0542.
   PubMed     Abstract available
   
   
   
2. SU J, Wollenberg A, Funk M, Mesaric T, et al
   Redefining Treat-to-target in Atopic Dermatitis: Towards Meaningful, Patient-centred Disease Control - An ISAD Position Paper.
   Acta Derm Venereol. 2026;106.
   PubMed     Abstract available
   
   
   
3. AMICI JM, Doutre MS, Halioua B, Bourne Chastel A, et al
   Clinical Phenotyping of Atopic Dermatitis Using Combined Global Severity (POEM) and Facial Burden (BoFA): A French Population-based Observational Study.
   Acta Derm Venereol. 2026;106:0622.
   PubMed     Abstract available
   
   
   
4. TRAIDL S, Cornelius A, Heinrich L, Siegels D, et al
   Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry.
   Acta Derm Venereol. 2026;106:0616.
   PubMed     Abstract available
   
   
   
5. LAI T, Li C
   Commentary on "Reported Penicillin Allergy Affects the Length of Hospital Stay in Patients with Erysipelas".
   Acta Derm Venereol. 2026;106:0848.
   PubMed    
   
   
   
6. DENG P, Yuyang Y, Zeng J, Lu J, et al
   Plasma Metabolomic and Proteomic Profiling of the Mechanisms Underlying the Cumulative Impact of Co-occurring Psychiatric Disorders on Atopic Dermatitis.
   Acta Derm Venereol. 2026;106:0181.
   PubMed     Abstract available
   
   
   
7. MARTINEZ-SIMON JJ, Carrasco-Piernavieja L, Zhan Zhou E, Andreu-Barasoain MI, et al
   Early Clinical Response Predicts Treatment Persistence in Advanced Therapy-naive Atopic Dermatitis.
   Acta Derm Venereol. 2026;106:0778.
   PubMed     Abstract available
   
   
   July 2026
8. GAWAZ A, Yilmaz A, Fehrenbacher B, Riel S, et al
   Persistent SARS-CoV-2 Spike Protein in Vasculitic Skin Lesions after Infection or mRNA Vaccination: A Retrospective Case control Immunofluorescence Study.
   Acta Derm Venereol. 2026;106:0308.
   PubMed     Abstract available
   
   
   
9. LAULETTA G, Napolitano M, Brescia C, Di Vico F, et al
   Effectiveness of Baricitinib in Treating Atopic Dermatitis in Difficult-to-treat Areas: A Retrospective Real-world Study.
   Acta Derm Venereol. 2026;106:0386.
   PubMed    
   
   
   
10. CURMAN P, Olbrich H, Kridin K, Thaci D, et al
    Psychiatric Risk in Chronic Spontaneous Urticaria: A Retrospective Cohort Study.
    Acta Derm Venereol. 2026;106:0643.
    PubMed     Abstract available
    
    
    
11. PLANELLA-FONTANILLAS N, Berna-Rico E, Figueras-Nart I, Spertino J, et al
    Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study.
    Acta Derm Venereol. 2026;106:0485.
    PubMed     Abstract available
    
    
    June 2026
12. SHAHMORADI A, Kogel J, Scheithe N, Hitzenbichler F, et al
    Reported Penicillin Allergy Affects the Length of Hospital Stay in Patients with Erysipelas.
    Acta Derm Venereol. 2026;106:0572.
    PubMed     Abstract available
    
    
    
13. YU J, Schalock PC
    Aspects of Adverse Effects of Cosmetic Products: An Invited Narrative Review.
    Acta Derm Venereol. 2026;106:0340.
    PubMed     Abstract available
    
    
    
14. SCHETT A, Gabriel A, Tascilar K, Schett G, et al
    Organ Involvement and Treatment Response across Cutaneous Sarcoidosis Subtypes.
    Acta Derm Venereol. 2026;106:0482.
    PubMed     Abstract available
    
    
    
15. LIPINSKI A, Paulmann M, Muller S, Wagner D, et al
    "Drug Reaction with Eosinophilia and Systemic Symptoms" (DRESS): Long-term Outcomes Based on Severity - A Cohort Study.
    Acta Derm Venereol. 2026;106:0310.
    PubMed     Abstract available
    
    
    
16. AUGUSTIN M, Amerio P, Bewley A, Gieler U, et al
    Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course Impairment.
    Acta Derm Venereol. 2026;106:0066.
    PubMed     Abstract available
    
    
    
17. UTO M, Komiya E, Kojima G, Kamata Y, et al
    Association of Skin Dryness and Disease-related Parameters with Mechanical Alloknesis in Atopic Dermatitis: A Crosssectional and Prospective Cohort Study.
    Acta Derm Venereol. 2026;106:0246.
    PubMed     Abstract available
    
    
    
18. WOLLENBERG A, Silverberg JI, Legat FJ, Tauber M, et al
    Efficacy and Safety of Nemolizumab at Week 48: Results from the Maintenance Phase of Two Global Phase 3 Pivotal Studies (ARCADIA 1&2) in Patients with Moderate-to-Severe Atopic Dermatitis.
    Acta Derm Venereol. 2026;106:0085.
    PubMed     Abstract available
    
    
    
19. METSINI A, Ryen L, Montgomery S, Molarius A, et al
    Relationship between Dermatology Life Quality Index Scores and EQ-5D-5L Utility Values in Adults with Atopic Dermatitis: Development of a Swedish Mapping Model.
    Acta Derm Venereol. 2026;106:0277.
    PubMed     Abstract available
    
    
    May 2026
20. BOESJES C, Bruin-Weller M, Zuithoff NPA, Bouhaddani SE, et al
    A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermany.
    Acta Derm Venereol. 2026;106:0231.
    PubMed     Abstract available
    
    
    
21. THACI D, Puig L, Motegi SI, Papp K, et al
    Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.
    Acta Derm Venereol. 2026;106:0160.
    PubMed     Abstract available
    
    
    
22. NORRESLET LB, Agner T, Mortz CG
    Pregnancy in Women with Atopic Dermatitis: A Systematic Review of Concerns and Challenges.
    Acta Derm Venereol. 2026;106:0608.
    PubMed     Abstract available
    
    
    
23. LI L, Chen Y, Lin M, Hou L, et al
    Real-world Efficacy and Safety of Stapokibart in Children and Adolescents with Moderate-to-severe Atopic Dermatitis: A Retrospective Study.
    Acta Derm Venereol. 2026;106:0258.
    PubMed     Abstract available
    
    
    April 2026
24. KLINGER T, Augustin M, Baumeister S, Riedel J, et al
    Epidemiology and Comorbidity of Vitiligo in Germany: A Claims Data Analysis.
    Acta Derm Venereol. 2026;106:adv44468.
    PubMed     Abstract available
    
    
    
25. HOREV A, Gabay S, Valdman-Grinshpoun Y, Alfer T, et al
    Noninvasive Skin Surface Sampling Identifies Elevated IL-1beta and IL-6 in Paediatric Atopic Dermatitis Patients.
    Acta Derm Venereol. 2026;106:0010.
    PubMed     Abstract available
    
    
    
26. PEZZOLO E, Mariateresa R, Luyo Saboya RA, Malagoli P, et al
    Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).
    Acta Derm Venereol. 2026;106:0193.
    PubMed     Abstract available
    
    
    March 2026
27. MICALI G, Lacarrubba F, Musumeci ML, Mantegazza R, et al
    Line-field Confocal Optical Coherence Tomography Detects Subclinical Disease Activity in Atopic Dermatitis during Treatment with Pimecrolimus: An Intrapatient, Controlled Study.
    Acta Derm Venereol. 2026;106:0399.
    PubMed    
    
    
    
28. METSINI A, Ryen L, Montgomery S, Molarius A, et al
    Quality of Life and Economic Burden in Swedish Adults with Atopic Dermatitis: A Cross-sectional Survey of Patientreported Outcomes.
    Acta Derm Venereol. 2026;106:0184.
    PubMed     Abstract available
    
    
    
29. CHEW BONILLA E, Vega-Del Pilar YX, Vilchis Chaparro E, Lemini Lopez A, et al
    Clinically Meaningful Improvement in Atopic Dermatitis According to Treatment Type in a Real- World Cohort.
    Acta Derm Venereol. 2026;106.
    PubMed    
    
    
    
30. NIEMEYER I, Salameh P, Linss HH, Grekowitz EM, et al
    Catastrophizing in Chronic Itch: Associations with Demographic, Clinical and Psychological Factors.
    Acta Derm Venereol. 2026;106:1-8.
    PubMed     Abstract available
    
    
    February 2026
31. RANGEN JK, Dalager MG
    Case Report Concerning a Varicella Zoster Virus Infection in a Six-year-old Child Receiving Dupilumab for Atopic Dermatitis.
    Acta Derm Venereol. 2026;106:1-2.
    PubMed    
    
    
    
32. VINGE AS, Altintas S, Odum N, Johansen JD, et al
    Assessing Targeted Proteomics in Inflammatory Skin Diseases with the Tape-stripping Method.
    Acta Derm Venereol. 2026;106:adv43362.
    PubMed     Abstract available
    
    
    
33. IBLER K, Haerskjold A, Olsen J, Themstrup L, et al
    Atopic Dermatitis in Denmark: Regional Variation.
    Acta Derm Venereol. 2026;106:adv44122.
    PubMed     Abstract available
    
    
    January 2026
34. WANG S, Vaz R, Lysell J, Eisfeldt J, et al
    The Role of the Cysteamine Dioxygenase (ADO) Gene in Atopic Dermatitis.
    Acta Derm Venereol. 2026;106:adv43770.
    PubMed     Abstract available
    
    
    
35. LU L, Feng J, He H, Peng Y, et al
    X-linked Recessive Ectodysplasin A Mutations Induced Hypohidrotic Ectodermal Dysplasia and Severe Atopic Dermatitis Successfully Treated with Dupilumab.
    Acta Derm Venereol. 2026;106:adv44646.
    PubMed    
    
    
    
36. WALIGORA-DZIWAK K, Kubiak KB, Danczak-Pazdrowska A, Jenerowicz D, et al
    How Adequately is the Severity of Atopic Dermatitis Assessed by Resident Physicians Training in Dermatology? Evaluation of the Intrarater and Interrater Reliability of Clinical Scoring Systems (EASI, oSCORAD, IGA, TIS Score, SASSAD).
    Acta Derm Venereol. 2026;106:adv43964.
    PubMed     Abstract available
    
    
    December 2025
37. HALIOUA B, Taieb C, Merhand S, Staumont-Salle D, et al
    Predictors of Patient Satisfaction in Atopic Dermatitis.
    Acta Derm Venereol. 2025;105:0096.
    PubMed    
    
    
    
38. ZHANG Q, Zhu Y, Yang L, Zeng Y, et al
    Efficacy and Safety of Abrocitinib in an Elderly Chinese Population with Moderate-to-Severe Atopic Dermatitis: A Non-randomized Controlled Trial.
    Acta Derm Venereol. 2025;105:adv44200.
    PubMed     Abstract available
    
    
    November 2025
39. YU Y, Chen Y, Zhang Y, Chen M, et al
    Short-term Abrocitinib Combined with Medicated Topical Therapy Provides Rapid Improvement in Pruritus in Elderly Patients with Moderate-to-severe Atopic Dermatitis: A Retrospective, Observational Real-world Study.
    Acta Derm Venereol. 2025;105:adv44210.
    PubMed     Abstract available
    
    
    
40. SCHLOSSER AR, Caron AGM, Den Ouden MS, Baart SJ, et al
    Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study.
    Acta Derm Venereol. 2025;105:adv44165.
    PubMed     Abstract available
    
    
    October 2025
41. MATHIEU C, Maccari F, Perrot JL, Reguiai Z, et al
    Clinical Impact of Systemic Treatment Choices Made in Current Practice in Elderly Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2025;105:adv44174.
    PubMed     Abstract available
    
    
    
42. 
    Abstracts from 15th Georg Rajka International Symposium on Atopic Dermatitis.
    Acta Derm Venereol. 2025;105:adv44874.
    PubMed     Abstract available
    
    
    
43. PESQUE D, Torros-Boso P, Andrades E, Pujol RM, et al
    Characterization of Contact Urticaria Syndrome Phenotypes: A Retrospective Study of 95 Cases.
    Acta Derm Venereol. 2025;105:adv43837.
    PubMed     Abstract available
    
    
    
44. GORI N, Sernicola A, Elena Ippoliti, Coppola R, et al
    Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations.
    Acta Derm Venereol. 2025;105:adv43523.
    PubMed     Abstract available
    
    
    September 2025
45. LIU Y, Wang P, Zhang C, Chen W, et al
    Knowledge, Attitude, and Practice Towards Urticaria in an Online Sample of the Chinese General Population.
    Acta Derm Venereol. 2025;105:adv43859.
    PubMed     Abstract available
    
    
    
46. MIZUASHI M
    Baricitinib 2 mg/day as a Cost-conscious Entry Point to Systemic Therapy in Moderate-to-severe Atopic Dermatitis: Real-world Data from a Japanese Clinic.
    Acta Derm Venereol. 2025;105:adv43616.
    PubMed    
    
    
    August 2025
47. TRAVE I, Salvi I, Canameri R, Cutolo CA, et al
    High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab.
    Acta Derm Venereol. 2025;105:adv43322.
    PubMed    
    
    
    
48. JONSSON PO, Tayefi M, Svedbom A, Bradley M, et al
    Drug Survival and Predictors of Systemic Treatment Outcome in Atopic Dermatitis: Data From a Nationwide Swedish Cohort.
    Acta Derm Venereol. 2025;105:adv43464.
    PubMed     Abstract available
    
    
    
49. WANG R, Ren C, Li Y, Guo B, et al
    The Impact of Clustered Care on Itch Severity and Sleep Quality in Patients with Atopic Dermatitis via an Online Platform.
    Acta Derm Venereol. 2025;105:adv43525.
    PubMed     Abstract available
    
    
    
50. LI Y, Peng R, Xue J, Zhao Y, et al
    The Predictive Value of Serum Total IgE for Antihistamine Treatment Outcomes in Chinese Patients with Chronic Spontaneous Urticaria.
    Acta Derm Venereol. 2025;105:adv43568.
    PubMed     Abstract available
    
    
    July 2025
51. WILLNER J, Bruze M, Dahlin J, Davidson Kallberg K, et al
    Occupational Sensitization to Colophony Subsequently Giving Rise to Both Environmental and Occupational Allergic Contact Dermatitis.
    Acta Derm Venereol. 2025;105:adv43296.
    PubMed    
    
    
    
52. SINIKUMPU SP, Jokelainen J, Huilaja L
    Allergic Contact Dermatitis in a Paediatric Population: A 20-year Nationwide Registry-based Study.
    Acta Derm Venereol. 2025;105:adv43557.
    PubMed    
    
    
    
53. ZHANG J, Zhu S, Yuan L, Yu X, et al
    Assessing Atopic Dermatitis Control in Chinese Patients: Validation of the Chinese Version of Recap of Atopic Eczema Questionnaire (RECAP) and an Investigation into Its Interpretability.
    Acta Derm Venereol. 2025;105:adv43458.
    PubMed     Abstract available
    
    
    
54. NYMAND LK, Nielsen ML, Christensen MO, Thomsen SF, et al
    Impact of Long-term Stability on Mental Health in Adults with Atopic Dermatitis: A Cohort Study with Unsupervised Cluster Analysis.
    Acta Derm Venereol. 2025;105:adv43071.
    PubMed     Abstract available
    
    
    June 2025
55. CHRISTENSEN MO, Vittrup I, Elberling J, Skov L, et al
    Prevalence of Asthma and Asthma Severity Among Patients with Moderate-Severe Atopic Dermatitis Treated with Advanced Systemics.
    Acta Derm Venereol. 2025;105:adv43415.
    PubMed    
    
    
    
56. HERRMANN L, Andreev S, Ziegler R, Neubauer C, et al
    Long-term Progressive Improvement of Atopic Dermatitis by an Herbal Emollient Plus Combination in a 12-week Clinical Trial.
    Acta Derm Venereol. 2025;105:adv43026.
    PubMed     Abstract available
    
    
    
57. SILVERBERG JI, Kerob D, Le Floc'h C, Taieb C, et al
    Atopic Dermatitis and Parental Guilt in the United States: Results of a Nationwide Study.
    Acta Derm Venereol. 2025;105:adv43444.
    PubMed    
    
    
    May 2025
58. KIND B, Heinrich L, Werfel T, Schmitt J, et al
    Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry.
    Acta Derm Venereol. 2025;105:adv42206.
    PubMed    
    
    
    
59. MAHMOOD SF, Mahmood WN, Abdalla OM, Nazar A, et al
    Leukotriene Receptor Antagonists for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis.
    Acta Derm Venereol. 2025;105:adv43140.
    PubMed     Abstract available
    
    
    
60. SPITZER C, Buchholz I, Lubke L, Wulfing C, et al
    Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach.
    Acta Derm Venereol. 2025;105:adv42794.
    PubMed     Abstract available
    
    
    
61. WU Z, Wu C, Chen X, Qian Q, et al
    Bidirectional Relationship Between Atopic Dermatitis and Psychiatric Comorbidities in Individuals of European Ancestry: A Mendelian Randomization Study.
    Acta Derm Venereol. 2025;105:adv43133.
    PubMed     Abstract available
    
    
    
62. LILJENDAHL MS, Ibler K, Vestergaard C, Skov L, et al
    Identifying Mild-to-Moderate Atopic Dermatitis Using a Generic Machine Learning Approach: A Danish National Health Register Study.
    Acta Derm Venereol. 2025;105:adv42250.
    PubMed     Abstract available
    
    
    
63. RAISANEN E, Remitz A, Salava A
    Seasonal Variation of the Burden of Atopic Dermatitis in Finnish Primary Care: A Database Study on Effects of Weather and Air Quality.
    Acta Derm Venereol. 2025;105:adv43041.
    PubMed     Abstract available
    
    
    April 2025
64. JUNGE A, Radonjic-Hoesli S, Bossart S, Simon D, et al
    Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation.
    Acta Derm Venereol. 2025;105:adv42401.
    PubMed     Abstract available
    
    
    
65. REMITZ A, Peltonen EJ, Korhonen L, Nortamo P, et al
    Characterizing Patients and Treatment Patterns in Moderate-to-severe Atopic Dermatitis in Finland: A Population-based Study Using National Health Data.
    Acta Derm Venereol. 2025;105:adv41244.
    PubMed     Abstract available
    
    
    
66. HEDMAN L, Lindberg M, Stenberg B, Ronmark E, et al
    Self-reported Nickel Allergy among Schoolchildren: Trends in Prevalence, Risk Factors, and Atopic Comorbidity.
    Acta Derm Venereol. 2025;105:adv42425.
    PubMed     Abstract available
    
    
    
67. FUENTES-BARRAGAN L, Garcia-Moronta C, Sanabria-de la Torre R, Leon-Perez FJ, et al
    Impact on Major Life-changing Decisions in Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2025;105:adv42241.
    PubMed     Abstract available
    
    
    March 2025
68. HOPKINS K, Antelmi A, Dahlin J, Olsson K, et al
    Clinical Relevance of Contact Allergy to Gold Sodium Thiosulphate in Fibromyalgia.
    Acta Derm Venereol. 2025;105:adv42463.
    PubMed     Abstract available
    
    
    
69. MULLER S, Zeidler C, Mess C, Kahnert SM, et al
    Patient Needs and Treatment Goals in Chronic Atopic Pruritus: Does Eczema Make a Difference?
    Acta Derm Venereol. 2025;105:adv42773.
    PubMed     Abstract available
    
    
    
70. CALABRESE L, Cinotti E, D'Onghia M, Cartocci A, et al
    Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study.
    Acta Derm Venereol. 2025;105:adv42275.
    PubMed     Abstract available
    
    
    
71. SCHLOSSER AR, Nijman L, Schappin R, Nijsten TEC, et al
    Long-term Outcomes of New Systemic Agents in Atopic Dermatitis: Drug Survival Analyses and Treatment Patterns in Daily Practice.
    Acta Derm Venereol. 2025;105:adv41504.
    PubMed     Abstract available
    
    
    
72. SKOVSGARD CH, Frolunde AS, Deleuran M, Thyssen JP, et al
    Counselling Needs in Atopic Dermatitis: Perspectives on Pregnancy and Treatment.
    Acta Derm Venereol. 2025;105:adv42544.
    PubMed     Abstract available
    
    
    
73. LINAN-BARROSO JM, Hernandez-Rodriguez JC, Ruiz-Villaverde R, Galan Gutierrez M, et al
    Definition of the Concept of Super-responders in Atopic Dermatitis: A Spanish Delphi Consensus.
    Acta Derm Venereol. 2025;105:adv42240.
    PubMed     Abstract available
    
    
    
74. ZHANG YT, Li HM, Zhang YJ, Tan C, et al
    Seasonal Changes in the Severity of Atopic Dermatitis by Birth Season: A Pilot Prospective Cohort Study.
    Acta Derm Venereol. 2025;105:adv41987.
    PubMed    
    
    
    February 2025
75. EZZEDINE K, Seneschal J, Corgibet F, Halioua B, et al
    The Impact of Atopic Dermatitis on Employment and Productivity: A French Study.
    Acta Derm Venereol. 2025;105:adv42734.
    PubMed    
    
    
    
76. BUDAIR FM, Alfaraj MM, Alharthi KA, Altabash MW, et al
    Azathioprine Hypersensitivity Syndrome Mimicking Herpes Zoster and Linear IgA Dermatosis Presentation: A Case Report.
    Acta Derm Venereol. 2025;105:adv42536.
    PubMed    
    
    
    
77. ZHANG J, Miltner L, Loman L, Ragamin A, et al
    Validation of the Atopic Dermatitis Control Tool (ADCT) and a Comparison with the Recap of Atopic Eczema Questionnaire (RECAP).
    Acta Derm Venereol. 2025;105:adv42364.
    PubMed     Abstract available
    
    
    
78. HASHIZUME H, Matsuura A, Ishikawa Y, Hata A, et al
    Flounder Roe Triggering alpha-Gal Syndrome: Hyosophorin as a Possible Allergen.
    Acta Derm Venereol. 2025;105:adv42664.
    PubMed    
    
    
    
79. SANCHEZ-GARCIA V, De-Miguel-Balsa E, Ramos-Rincon JM, Belinchon-Romero I, et al
    Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis.
    Acta Derm Venereol. 2025;105:adv41307.
    PubMed     Abstract available
    
    
    
80. LEE HJ, Woo Y, Lee YB, Lee JH, et al
    Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study.
    Acta Derm Venereol. 2025;105:adv40704.
    PubMed     Abstract available
    
    
    January 2025
81. TOYOTA S, Kogure T, Kondo E, Yasuda KI, et al
    Scratch Scoring by a Sheet-shaped Body Vibrometer in Nocturnal Sleep: A Pilot Study Compared with Infrared Video Recording.
    Acta Derm Venereol. 2025;105:adv41414.
    PubMed     Abstract available
    
    
    
82. THEODOSIOU G, Sterner T, Hiyoshi A, Carlberg M, et al
    Associations of Atopic Dermatitis in Late Adolescence with Occupation, Mental Health, Income from Work and Marital Status: A National Longitudinal Study.
    Acta Derm Venereol. 2025;105:adv42127.
    PubMed     Abstract available
    
    
    
83. KAMPHUIS E, Loman L, De Bruin-Weller M, Schuttelaar ML, et al
    Exploring Social Health in Patients with Atopic Dermatitis: An Observational, Cross-sectional, Questionnaire Based Study on Social Participation and Emotional Support.
    Acta Derm Venereol. 2025;105:adv41129.
    PubMed    
    
    
    
84. MAZILU R, Ziehfreund S, Biedermann T, Zink A, et al
    Patterns of Addiction in Chronic Skin Diseases: A Comparative Analysis of Addictions and Influencing Factors in Atopic Dermatitis and Psoriasis.
    Acta Derm Venereol. 2025;105:adv41350.
    PubMed     Abstract available
    
    
    
85. SOPENLEHTO A, Jokelainen J, Huilaja L, Sinikumpu SP, et al
    Atopic Dermatitis And Intercourse Difficulties : A Cross-sectional Study of the Northern Finland Birth Cohort 1966 Study.
    Acta Derm Venereol. 2025;105:adv40785.
    PubMed    
    
    
    
86. GWAK YS, Kim SY, Woo CE, Shin K, et al
    Association between Atopic Dermatitis and Dementia: Evidence from Systematic Review, Meta-analysis, and Mendelian Randomization.
    Acta Derm Venereol. 2025;105:adv41321.
    PubMed     Abstract available
    
    
    
87. ALSTERHOLM M, Af Klinteberg M, Vrang S, Sigurdardottir G, et al
    Topical Steroid Withdrawal in Atopic Dermatitis: Patient-reported Characterization from a Swedish Social Media Questionnaire.
    Acta Derm Venereol. 2025;105:adv40187.
    PubMed     Abstract available
    
    
    December 2024
88. SCHMIDT SAJ, Kristiansen E, Sorensen HT, Vestergaard C, et al
    Varicella-zoster Virus Infections in Patients with Hospital-diagnosed Atopic Dermatitis.
    Acta Derm Venereol. 2024;104:adv42326.
    PubMed    
    
    
    
89. FARGEAS M, Fauvernier M, Tauber M, Seneschal J, et al
    Effect of Therapeutic Patient Education in Adults with Atopic Dermatitis: Analysis of Efficacy and Treatment Needs.
    Acta Derm Venereol. 2024;104:adv41184.
    PubMed     Abstract available
    
    
    
90. WANG Y, Huang W, Jia H, Tang Q, et al
    Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-induced Skin Inflammation.
    Acta Derm Venereol. 2024;104:adv40975.
    PubMed     Abstract available
    
    
    November 2024
91. TAYEFI M, Svedbom A, Ivert L, Lundqvist M, et al
    Risk Factors Associated with Weight Gain during Treatment with Dupilumab among Patients with Moderate to Severe Atopic Dermatitis.
    Acta Derm Venereol. 2024;104:adv40796.
    PubMed     Abstract available
    
    
    
92. BLANCO SEQUEIROS A, Sinikumpu SP, Jokelainen J, Huilaja L, et al
    Psychiatric Comorbidities of Childhood-onset Atopic Dermatitis in Relation to Eczema Severity: A Register-based Study among 28,000 Subjects in Finland.
    Acta Derm Venereol. 2024;104:adv40790.
    PubMed     Abstract available
    
    
    
93. DASCALU J, Polansky S, Khamaysi Z, Avitan-Hersh E, et al
    Is the Use of the Extended (Meth)acrylate Series - Nails Justified? Characterization of Nail Acrylate Allergy in a Tertiary Medical Centre.
    Acta Derm Venereol. 2024;104:adv41079.
    PubMed     Abstract available
    
    
    October 2024
94. KHOSRAVI A, Glinska J, Baranska-Rybak W
    Sleep Efficiency and Neurocognitive Decline in Atopic Dermatitis: A Systematic Review.
    Acta Derm Venereol. 2024;104:adv40459.
    PubMed     Abstract available
    
    
    
95. LISTED NA
    Abstracts from 14th Georg Rajka International Symposium on Atopic Dermatitis.
    Acta Derm Venereol. 2024;104:adv42247.
    PubMed     Abstract available
    
    
    September 2024
96. TRAVE I, Salvi I, Bagnasco D, Parodi A, et al
    Tralokinumab as an Alternative to Dupilumab in a Patient with Atopic Dermatitis and Asthma who Developed Hypereosinophilia: A Case Report.
    Acta Derm Venereol. 2024;104:adv40800.
    PubMed    
    
    
    
97. RUSSO G, Dumont S, Menzinger S, Pastor D, et al
    Severe Acute Generalized Exanthematous Pustulosis Successfully Treated by Spesolimab.
    Acta Derm Venereol. 2024;104:adv41311.
    PubMed    
    
    
    
98. MARIEN C, Kamgang Semeu P
    Diffuse Pain Revealing Clinically Unapparent Subcutaneous Sarcoidosis.
    Acta Derm Venereol. 2024;104:adv41137.
    PubMed    
    
    
    
99. POLLYN-MILLOT C, Maccari F, Perrot JL, Reguiai Z, et al
    Clinical Characteristics and Therapeutic Management of Atopic Dermatitis in Elderly Patients Compared with Young Adult Patients: A Prospective Multicentre Study.
    Acta Derm Venereol. 2024;104:adv40420.
    PubMed     Abstract available
    
    
    
100. TANAKA A, Igawa K, Takahashi H, Shimizu R, et al
     Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis.
     Acta Derm Venereol. 2024;104:adv34375.
     PubMed     Abstract available
     
     
     
101. KATSUTA M, Kamide R, Ishiuji Y, Nobeyama Y, et al
     Bullous Pemphigoid that Developed During Nemolizumab Treatment for Atopic Dermatitis: Two Case Reports.
     Acta Derm Venereol. 2024;104:adv40634.
     PubMed    
     
     
     August 2024
102. MAROVT M, Marko PB
     Denosumab-induced Acute Generalized Exanthematous Pustulosis.
     Acta Derm Venereol. 2024;104:adv40430.
     PubMed    
     
     
     
103. SUKAKUL T, Bruze M, Svedman C
     Fragrance Contact Allergy - A Review Focusing on Patch Testing.
     Acta Derm Venereol. 2024;104:adv40332.
     PubMed     Abstract available
     
     
     
104. SANG X, Lu J, Tan L, Zeng J, et al
     The Circadian Rhythm of Itching among 241 Adults with Atopic Dermatitis: A Cross-sectional Study.
     Acta Derm Venereol. 2024;104:adv35427.
     PubMed     Abstract available
     
     
     June 2024
105. XIAO M, Zhang X, Guo A, Zhang K, et al
     A Retrospective Cohort Study on the Comorbidity in 19,264 Chinese Patients of Different Ages with Urticaria.
     Acta Derm Venereol. 2024;104:adv24050.
     PubMed     Abstract available
     
     
     
106. SIGURDARDOTTIR G, Alsterholm M, Andersson CD, Bradley M, et al
     Cross-Cultural Validation of the RECAP of Atopic Eczema Question-naire in a Swedish Population.
     Acta Derm Venereol. 2024;104:adv38889.
     PubMed     Abstract available
     
     
     
107. FLUHR JW, Herzog L, Darlenski R, Mentel T, et al
     Short-term Heat Application Reduces Itch Intensity in Atopic Dermatitis: Insights from Mechanical Induction and Real-life Episodes.
     Acta Derm Venereol. 2024;104:adv40127.
     PubMed     Abstract available
     
     
     
108. RODRIGUEZ-POZO JA, Montero-Vilchez T, Diaz Calvillo P, Sanabria de la Torre R, et al
     The Impact of Atopic Dermatitis on Sexual Function and Reproductive Desires in Women.
     Acta Derm Venereol. 2024;104:adv35107.
     PubMed     Abstract available
     
     
     
109. RATUSZNIK N, Edslev SM, Stegger M, Soderquist B, et al
     Superantigen Encoding Genes in Staphylococcus aureus Isolated from Lesional Skin, Non-Lesional Skin, and Nares of Patients with Atopic Dermatitis.
     Acta Derm Venereol. 2024;104:adv34882.
     PubMed     Abstract available
     
     
     
110. FAERK G, Ahlstrom MG, Lura VH, Reventlow S, et al
     Referral Pathways for Children with Atopic Diseases in Denmark.
     Acta Derm Venereol. 2024;104:adv34961.
     PubMed     Abstract available
     
     
     May 2024
111. VAN ENST WA, Weng YC, Wanten SAC, Seyger MMB, et al
     Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review.
     Acta Derm Venereol. 2024;104:adv23901.
     PubMed     Abstract available
     
     
     
112. YEW YW, Phuan CZY, Zhao X, Howells L, et al
     Validation of the Recap of Atopic Eczema (RECAP) Measurement Instrument for Eczema Control in Adult Patients in an Asian Clinical Setting.
     Acta Derm Venereol. 2024;104:adv32323.
     PubMed     Abstract available
     
     
     
113. FOUGEROUSSE AC, Alexandre M, Darrigade AS, Merhand S, et al
     Impact of Atopic Dermatitis on Adult Women's Lives: A Survey of 1,009 French Women.
     Acta Derm Venereol. 2024;104:adv10321.
     PubMed     Abstract available
     
     
     
114. SANDBERG A, Lassenius M, Vihervaara V, Toppila I, et al
     Hereditary Angioedema Type 1 and 2 in Finland: Incidence, Prevalence, and Preceding Diagnoses.
     Acta Derm Venereol. 2024;104:adv24176.
     PubMed    
     
     
     
115. KWATRA SG, De Bruin-Weller M, Silverberg JI, Lio P, et al
     Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib.
     Acta Derm Venereol. 2024;104:adv18452.
     PubMed     Abstract available
     
     
     
116. DE VEER MR, Kranenburg LW, Nijsten TEC, Busschbach JJ, et al
     Eye Movement Desensitization Protocol for Urge to Reduce Scratching Behaviour in Patients with Prurigo Nodularis: A Pilot Study.
     Acta Derm Venereol. 2024;104:adv39945.
     PubMed    
     
     
     April 2024
117. ZAKIUDIN DP, Thyssen JP, Zachariae C, Videm V, et al
     Filaggrin Mutation Status and Prevention of Atopic Dermatitis with Maternal Probiotic Supplementation.
     Acta Derm Venereol. 2024;104:adv24360.
     PubMed     Abstract available
     
     
     
118. ANDRE N, Alyagon A, Jurban E, Moscovici K, et al
     Does Molluscum Contagiosum Need to be Managed Differently in Atopic Children?
     Acta Derm Venereol. 2024;104:adv39983.
     PubMed     Abstract available
     
     
     
119. WEISSMANN S, Burrack N, Golan-Tripto I, Horev A, et al
     Increased Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Chronic and Severe Urticaria.
     Acta Derm Venereol. 2024;104:adv23932.
     PubMed     Abstract available
     
     
     
120. FIGUERAS I, Feito M, Garcia-Bustinduy M, Monte-Boquet E, et al
     A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis.
     Acta Derm Venereol. 2024;104:adv18255.
     PubMed     Abstract available
     
     
     
121. RUSSO G, Laffitte E
     Successful Therapy of Severe and Refractory Cutaneous Sarcoidosis with Baricitinib.
     Acta Derm Venereol. 2024;104:adv39970.
     PubMed    
     
     
     
122. ZHAO Q, Tominaga M, Toyama S, Komiya E, et al
     Effects of Psychological Stress on Spontaneous Itch and Mechanical Alloknesis of Atopic Dermatitis.
     Acta Derm Venereol. 2024;104:adv18685.
     PubMed     Abstract available
     
     
     March 2024
123. BAUDY A, Raison-Peyron N, Serrand C, Crepy MN, et al
     Impact of Chronic Spontaneous or Inducible Urticaria on Occupational Activity.
     Acta Derm Venereol. 2024;104:adv36122.
     PubMed     Abstract available
     
     
     
124. ULRIKSDOTTER J, Sukakul T, Bruze M, Mowitz M, et al
     Contact Allergy to Allergens in the Swedish Baseline Series Overrepresented in Diabetes Patients with Skin Reactions to Medical Devices - A Retrospective Study from Southern Sweden.
     Acta Derm Venereol. 2024;104:adv19676.
     PubMed     Abstract available
     
     
     
125. MAGEN E, Merzon E, Green I, Vinker S, et al
     Dermatological Comorbidities in Patients with Acute Urticaria.
     Acta Derm Venereol. 2024;104:adv18399.
     PubMed    
     
     
     
126. CASSALIA F, Cazzaniga S, Ofenloch R, Elsner P, et al
     Comparison of Perceptions of Skin Condition, Product Use and Allergen Reactivity Between People with Psoriasis and Controls in the European Dermato-Epidemiology Network (EDEN) Fragrance Study.
     Acta Derm Venereol. 2024;104:adv23513.
     PubMed     Abstract available
     
     
     February 2024
127. LUNDGREN S, Sonesson A
     Effect of Potassium Permanganate on Staphylococcal Isolates Derived from the Skin of Patients with Atopic Dermatitis.
     Acta Derm Venereol. 2024;104:adv18642.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum